HomeNews

News

Oxford launches first human trial of aerosol vaccine delivery

Oxford launches first human aerosol TB challenge trial

Global health
Medical Sciences
Research
Vaccines
Breakthrough aerosol human infection model gives hope for future tuberculosis vaccine development

Oxford marks World Tuberculosis Day as vaccine trials continue

Global health
Medical Sciences
Research
Vaccines
IOI awards £5m to Oxford consortium to develop new therapies for drug-resistant tuberculosis

IOI awards £5m to Oxford consortium to develop new therapies for drug-resistant tuberculosis

Funding
Global health
Health
Mathematical, Physical and Life Sciences
Medical Sciences
Vaccines
Oxford Laboratory

Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research

Cancer
Funding
Global health
Medical Sciences
Vaccines
Anopheles mosquito

First vaccine against blood-stage malaria is well-tolerated and offers effective protection

Global health
Malaria
Medical Sciences
Research
Vaccines
Typhoid Vaccine Trial

Typhoid vaccine trial confirms sustained protection for older children

Global health
Medical Sciences
Research
Vaccines
Ovarian Cancer

Oxford researchers secure funding for world's first ovarian cancer prevention vaccine

Cancer
Funding
Global health
Medical Sciences
Research
Vaccines
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation

Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation

Arts
Coronavirus
COVID-19 vaccine
Ebola
Medical Sciences
Vaccines
Vaccines and syringes

New shingles vaccine could reduce risk of dementia

Brain health
Medical Sciences
Neuroscience
Research
Vaccines
Abidjan, Côte d’Ivoire: First baby receiving the new R21/Matrix-M™ malaria vaccine, co-developed by the University of Oxford and Serum Institute of India

Côte d’Ivoire makes history as first nation to deploy R21/Matrix-M™ Malaria Vaccine

Global health
Malaria
Vaccines

Pages